{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:54:19Z","timestamp":1789872859387,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jaip.2024.12.035","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T12:37:39Z","timestamp":1735648659000},"page":"670-679.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Randomized Comparison of Bencycloquidium Bromide, Mometasone Furoate, and a Combination for Persistent Allergic Rhinitis"],"prefix":"10.1016","volume":"13","author":[{"given":"Xian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qintai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-9884","authenticated-orcid":false,"given":"Luo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.12.035_bib1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","article-title":"Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines-2016 revision","volume":"140","author":"Bro\u017cek","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.035_bib2","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2018.8.e7","article-title":"The International Study of the Allergic Rhinitis Survey: outcomes from 4 geographical regions","volume":"8","author":"Passali","year":"2018","journal-title":"Asia Pacific Allergy"},{"issue":"suppl 86","key":"10.1016\/j.jaip.2024.12.035_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.12.035_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2020.07.007","article-title":"Rhinitis 2020: a practice parameter update","volume":"146","author":"Dykewicz","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"suppl 2","key":"10.1016\/j.jaip.2024.12.035_bib5","first-page":"S35","article-title":"Pharmacotherapy for allergic rhinitis","volume":"4","author":"Platt","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.12.035_bib6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jama.2024.0530","article-title":"Allergic rhinitis","volume":"331","author":"Bernstein","year":"2024","journal-title":"Jama"},{"key":"10.1016\/j.jaip.2024.12.035_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.alit.2015.11.006","article-title":"Extranasal symptoms of allergic rhinitis are difficult to treat and affect quality of life","volume":"65","author":"Jaruvongvanich","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2024.12.035_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/iid3.237","article-title":"Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy","volume":"6","author":"Kaulsay","year":"2018","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaip.2024.12.035_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJM198808253190806","article-title":"Ipratropium bromide","volume":"319","author":"Gross","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.12.035_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/lary.30306","article-title":"Intranasal anticholinergics for treatment of chronic rhinitis: systematic review and meta-analysis","volume":"133","author":"Pang","year":"2022","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2024.12.035_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejphar.2011.01.017","article-title":"Characterization of bencycloquidium bromide, a novel muscarinic M(3) receptor antagonist in guinea pig airways","volume":"655","author":"Jiang","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaip.2024.12.035_bib12","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.2500\/ajra.2011.25.3604","article-title":"M1 and M3 muscarinic receptors mediate relaxation and contraction in canine nasal veins","volume":"25","author":"Lung","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2024.12.035_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/11599330-000000000-00000","article-title":"Pharmacokinetics, safety and tolerability of bencycloquidium bromide, a novel selective muscarinic M1\/M3 receptor antagonist, after single and multiple intranasal doses in healthy chinese subjects: an open-label, single-center, first-in-human study","volume":"12","author":"Sun","year":"2012","journal-title":"Drugs R D"},{"key":"10.1016\/j.jaip.2024.12.035_bib14","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1007\/s00405-020-06183-5","article-title":"Bencycloquidium bromide nasal spray is effective and safe for persistent allergic rhinitis: a phase III, multicenter, randomized, double-blinded, placebo-controlled clinical trial","volume":"277","author":"Jiang","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2024.12.035_bib15","first-page":"6","volume":"51","year":"2016","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10.1016\/j.jaip.2024.12.035_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2222.1991.tb00807.x","article-title":"Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis","volume":"21","author":"Juniper","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.12.035_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12913-016-1471-x","article-title":"Clinical and demographic correlates of medication and visit adherence in a large randomized controlled trial","volume":"16","author":"Whittle","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jaip.2024.12.035_bib18","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.3390\/pharmaceutics14112459","article-title":"Medication adherence to intranasal corticosteroids in allergic rhinitis patients with comorbid medical conditions","volume":"14","author":"Manjit Singh","year":"2022","journal-title":"pharmaceutics"},{"key":"10.1016\/j.jaip.2024.12.035_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0091-6749(99)70380-5","article-title":"Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire","volume":"104","author":"Juniper","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.035_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/1744666X.2023.2228493","article-title":"Development of a method of nasal secretions sampling for local nasal inflammation studies","volume":"19","author":"Xu","year":"2023","journal-title":"Exp Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.035_bib21","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.2500\/ajra.2010.24.3427","article-title":"Objective improvement in nasal congestion and nasal hyperreactivity with use of nasal steroids in persistent allergic rhinitis","volume":"24","author":"Wandalsen","year":"2010","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2024.12.035_bib22","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024)","author":"Higgins","year":"2024"},{"key":"10.1016\/j.jaip.2024.12.035_bib23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"Follmann","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2024.12.035_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0091-6749(92)90078-G","article-title":"Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology","volume":"90","author":"Meltzer","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.035_bib25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0091-6749(95)70217-2","article-title":"Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%","volume":"95","author":"Kaiser","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.035_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1081-1206(10)63284-X","article-title":"Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis","volume":"82","author":"Dockhorn","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.12.035_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2500\/108854198778557962","article-title":"The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis","volume":"19","author":"Kaiser","year":"1998","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.12.035_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00011-015-0800-6","article-title":"Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis","volume":"64","author":"Long","year":"2015","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jaip.2024.12.035_bib29","first-page":"106A","volume":"57","year":"2022","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10.1016\/j.jaip.2024.12.035_bib30","first-page":"108","article-title":"International Consensus Statement on Allergy and Rhinology: allergic rhinitis","volume":"8","author":"Wise","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.12.035_bib31","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/lary.30706","article-title":"Ipratropium bromide nasal spray in non-allergic rhinitis: a systematic review and meta-analysis","volume":"133","author":"El Khoury","year":"2023","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2024.12.035_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41577-019-0247-z","article-title":"Neuroimmune circuits in inter-organ communication","volume":"20","author":"Huh","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2024.12.035_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pupt.2012.07.003","article-title":"Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target","volume":"26","author":"Meurs","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2024.12.035_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2007.12.029","article-title":"Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB\/ERK-dependent mechanism","volume":"582","author":"Profita","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaip.2024.12.035_bib35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12890-022-01983-3","article-title":"Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium","volume":"22","author":"Katsumata","year":"2022","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.jaip.2024.12.035_bib36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaci.2023.10.031","article-title":"Cholinergic sensing of allergen exposure by airway epithelium promotes type 2 immunity in the lungs","volume":"153","author":"Hayashi","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.035_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/19458924221137977","article-title":"Antagonism of m3 alleviates type 2 inflammation in allergic rhinitis mice","volume":"37","author":"Chen","year":"2022","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2024.12.035_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4414\/smw.2009.12468","article-title":"Pathophysiology of itching and sneezing in allergic rhinitis","volume":"139","author":"Pfaar","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jaip.2024.12.035_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12016-010-8206-2","article-title":"Intranasal steroids in the treatment of allergy-induced rhinorrhea","volume":"41","author":"Nathan","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.12.035_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1573396320666230912103108","article-title":"Treatment of allergic rhinitis in clinical practice","volume":"20","author":"Tosca","year":"2024","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.jaip.2024.12.035_bib41","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1398-9995.2008.01750.x","article-title":"Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications","volume":"63","author":"Derendorf","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.12.035_fur1","first-page":"6","article-title":"[Chinese guidelines for diagnosis and treatment of allergic rhinitis]","volume":"51","year":"2016","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824012844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824012844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:15:44Z","timestamp":1762607744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824012844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213219824012844"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.12.035","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Comparison of Bencycloquidium Bromide, Mometasone Furoate, and a Combination for Persistent Allergic Rhinitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}